Home   |   Forum   |   Digest Archives   |   Issues   |   Contributors   |   Resources: Print + Online   |   Contact   |   Login

Stephen Soldz Research Note 2

11/13/2017 2:36 PM | Anonymous

In Part I last week, I discussed the Bastos et al. study out of Brazil that found long-term psychodynamic therapy (LTPDT) to have better outcomes than fluoxetine after 24 months of treatment. This week I’ll take a look at another recent study involving another randomized controlled trial (RCT) of LTPDT (called by the authors Long-term Psychoanalytic Psychotherapy or LTPP). In a study out of Britain, Peter Fonagy and colleagues examined the value of LTPDT as a therapy for treatment-resistant depression.

To read the full article, click here

© 2017 - Division | Review


Powered by Wild Apricot Membership Software